Detalhe da pesquisa
1.
Optical Biopsies Using Probe-Based Confocal Laser Endomicroscopy for Autoimmune Pulmonary Alveolar Proteinosis.
Respiration
; 103(4): 171-176, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387451
2.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci
; 114(2): 606-618, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169649
3.
Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.
Thorax
; 78(8): 784-791, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012071
4.
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Cancer Immunol Immunother
; 72(6): 1699-1707, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617602
5.
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
Oncologist
; 27(11): 903-e834, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181763
6.
The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib Treatment.
Biol Pharm Bull
; 44(9): 1280-1285, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162777
7.
Predictive risk factors for pneumothorax after transbronchial biopsy using endobronchial ultrasonography with a guide sheath.
BMC Pulm Med
; 21(1): 181, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051763
8.
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
Oncologist
; 24(5): 593-e170, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651400
9.
Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
BMC Pulm Med
; 19(1): 194, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675941
10.
Short hydration regimen with magnesium supplementation prevents cisplatin-induced nephrotoxicity in lung cancer: a retrospective analysis.
Support Care Cancer
; 25(4): 1215-1220, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27966021
11.
Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.
BMC Pulm Med
; 17(1): 175, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212495
12.
Celecoxib induced respiratory symptoms without urinary LTE 4 increase in a patient with AERD.
Allergol Int
; 70(3): 401-403, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33279400
13.
Bronchus sign on thin-section computed tomography is a powerful predictive factor for successful transbronchial biopsy using endobronchial ultrasound with a guide sheath for small peripheral lung lesions: a retrospective observational study.
BMC Med Imaging
; 15: 21, 2015 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092497
14.
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
Am J Respir Crit Care Med
; 188(8): 985-95, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23855620
15.
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
Front Immunol
; 15: 1348034, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464519
16.
Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
EBioMedicine
; 103: 105102, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614865
17.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Target Oncol
; 19(3): 423-433, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38613731
18.
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study.
Eur J Cancer
; 195: 113373, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890349
19.
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.
Target Oncol
; 18(5): 657-665, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610516
20.
Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial.
EClinicalMedicine
; 66: 102303, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38034077